AbbVie (ABBV) Asset Utilization Ratio (2013 - 2026)

AbbVie (ABBV) has reported Asset Utilization Ratio for 14 consecutive years, with 0.47 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio rose 11.11% year-over-year to 0.47 in Q2 2026; TTM through Jun 2026 was 0.47, a 11.11% increase from a year earlier, with the FY2025 full-year figure at 0.45, up 8.87% from the prior year.
• Asset Utilization Ratio was 0.47 for Q2 2026 at AbbVie, up from 0.46 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.47 in Q2 2026 and troughed at 0.38 in Q2 2024.
• A 5-year average of 0.42 and a median of 0.41 in 2022 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio increased 17.43% in 2022 and declined 8.88% in 2024, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.41 in 2022, then dropped by 3.26% to 0.4 in 2023, then climbed by 0.86% to 0.4 in 2024, then gained by 12.91% to 0.46 in 2025, then advanced by 3.83% to 0.47 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.47 (Q2 2026), 0.46 (Q1 2026), and 0.46 (Q4 2025), per Business Quant data.